What if you sell medicine that causes men to grow breasts?
Who’s reserving prison cells for Johnson & Johnson executives?
March 21, 2017 by Jon Rappoport
Who’s reserving the prison cells? The answer: no one.
These Johnson & Johnson execs are free and rich and powerful, although their crimes should have landed them in jail years ago.
And before I read the riot act, chapter and verse, let’s get something straight. Everybody’s talking about the Deep State? Well, Big Pharma is an essential part of the Deep State.
These princes are affecting, with toxic substances, the world population every day. All their lobbying efforts, all their behind-the-scenes political control guarantees they can continue to wage what amounts to chemical warfare on the public.
Today’s focus: Johnson & Johnson.
SCANDAL ONE: RISPERDAL.
March 8, 2017, ibtimes: “More than 100,000 patients are suing US group Johnson & Johnson, alleging that some of its products have caused them harm. They are claiming an antipsychotic medicine [Risperdal] has resulted in 18,500 men developing a condition known as gynecomastia, or breast swelling after taking the drugs as children.”
“Between 2016 and 2017, the number of lawsuits disclosed by J&J dramatically increased from 28,300 to 104,700, and along with it, the company’s legal costs, the Financial Times reports.”
“However, the troubles of J&J with Risperdal are not new. The company has been accused before of wrongly marketing the drug between 1999 and 2005, promoting it for uses not approved by the US Food and Drug Administration – including for the treatment of children with attention deficit hyperactivity disorder (ADHD).”
“In 2013, this led to the company paying more than $2.2bn to settle investigations into its marketing of the drug and other products.”
“This includes the case of a couple awarded $70m last year by a jury in Philadelphia after their son developed gynecomastia at the age of five, and a man who received $2.5m after growing size 46DD ‘female breasts’.”
This isn’t the only problem associated with Risperdal. Psychiatrist and author of Toxic Psychiatry, Peter Breggin, writes: “On May 26, 2000, a jury in the circuit court of Philadelphia awarded $6.7 million to a patient afflicted with tardive dyskinesia caused by the neuroleptic (“antipsychotic”) drug Risperdal (generic name, risperidone). In Liss vs. Doeff, the jury found the psychiatrist negligent in his treatment of Mrs. Elizabeth Liss. The case is among the first involving Risperdal, a relatively new neuroleptic that was put on the market in 1994 and originally promoted as relatively free of the risk of tardive dyskinesia. Peter R. Breggin, M.D., referred the case to the attorneys and acted as a medical consultant throughout the case.”
“Ms. Liss developed tardive dyskinesia during a fourteen-month period of exposure to Risperdal as a maintenance treatment for manic-depressive (bipolar) disorder. In previous years, she had several relatively brief exposures to other neuroleptics.”
“Tardive dyskinesia is a movement disorder caused by neuroleptic or ‘antipsychotic’ medications. It can afflict any voluntary muscles of control. It can become severe and disabling, and there are no effective treatments…[NOTE:] Withdrawal from antipsychotic drugs can cause overwhelming emotional and neurological suffering, as well as psychosis in both children and adults, making complete cessation at times very difficult or impossible.”
Is that enough? There’s more.
JOHNSON & JOHNSON SCANDAL TWO: TALC POWDER.
Ibtimes, 2017: “Other [Johnson & Johnson] drugs have also been blamed for causing harm to patients. More than 3,000 women have so far sued the company, claiming its talc powder caused them to develop ovarian cancer. They accuse J&J of failing to warn them about talc’s potential to increase the risk of ovarian cancer.”
“At the beginning of March, a St Louis jury rejected one of such lawsuits against J&J related to its talc-based products. However, other cases had previously been lost by the group. In February 2016, J&J was for instance ordered to pay out $72m to the family of a woman who died from ovarian cancer after using the firm’s products for years.”
JOHNSON & JOHNSON SCANDAL THREE: LEVAQUIN.
And then there was this—In 2012, Johnson & Johnson settled lawsuits against them for their antibiotic, Levaquin. FiercePharma writes:
“Johnson & Johnson ($JNJ) appears to be in settlement mode. It has knocked off some more pending litigation, having settled about 25% of the 3,400 lawsuits it faced tied to the dangers of taking antibiotic Levaquin…”
“In a filing in federal court, the drugmaker said it had agreed to settle, for an undisclosed sum, 845 of the legal actions brought by patients who claimed the drugmaker didn’t do enough to warn about the dangers of antibiotic Levaquin, which has been tied to tendon problems, Bloomberg reports. It said it is in negotiations to settle another 190 of the cases.”
“In 2008, the FDA required all makers of antibiotics that fell in the same class as Levaquin to add a ‘black box’ warning to the products that the fluoroquinolones were tied to higher risks of tendon ruptures.”
Medlineplus,gov spells it out further: “Taking levofloxacin [Levaquin] increases the risk that you will develop tendinitis (swelling of a fibrous tissue that connects a bone to a muscle) or have a tendon rupture (tearing of a fibrous tissue that connects a bone to a muscle) during your treatment or for up to several months afterward. These problems may affect tendons in your shoulder, your hand, the back of your ankle, or in other parts of your body. Tendinitis or tendon rupture may happen to people of any age, but the risk is highest in people over 60 years of age…Taking levofloxacin may cause changes in sensation and nerve damage that may not go away even after you stop taking levofloxacin…Taking levofloxacin may affect your brain or nervous system and cause serious side effects. This can occur after the first dose of levofloxacin.”
JOHNSON & JOHNSON SCANDAL FOUR: OVER-THE-COUNTER MEDICINES FOR CHILDREN AND INFANTS.
Let’s go even further back in time.
Washington Post, May 2, 2010: “A division of Johnson & Johnson is recalling 43 over-the-counter medicines made for infants and children — including liquid versions of Tylenol, Motrin, Zyrtec and Benadryl — after federal regulators identified what they called deficiencies at the company’s manufacturing facility.”
“The voluntary recall, which was announced late Friday by McNeil Consumer Healthcare [a subsidiary of Johnson & Johnson], affects hundreds of thousands of bottles of medicine in homes and on store shelves throughout the United States and its territories and in nine other countries — a vast portion of the children’s medicine market.”
“In a statement, the company said: ‘Some of the products included in the recall may contain a higher concentration of active ingredient than is specified; others contain inactive ingredients that may not meet internal testing requirements; and others may contain tiny particles.’ It said the problems may affect ‘purity, potency or quality’.”
“This is at least the third major recall of Tylenol products by McNeil since 2008.”
“In January , McNeil recalled 49 types of Tylenol products made for adults and two Tylenol products made for children after consumers complained of a mold-like odor and of temporary and minor nausea, stomach pain, vomiting and diarrhea. The company determined that some of the medicines had been contaminated by trace amounts of a chemical that is sometimes present on shipping and storage material.”
The NY Times, May 1, 2010, reported that Johnson & Johnson indicated the products might be contaminated with “tiny metal specks.”
JOHNSON & JOHNSON SCANDAL FIVE: HIP-REPLACEMENT RECALL.
Also, in 2010, Johnson & Johnson instituted a hip-replacement recall. Wikipedia: “On August 2009, 2010, DePuy, a subsidiary of American giant Johnson & Johnson, recalled its ASR (articular surface replacement) hip prostheses from the market…Pathologically, the failing prosthesis had several effects. Metal debris from wear of the implant led to a reaction that destroyed the soft tissues surrounding the joint, leaving some patients with long term disability. Ions of cobalt and chromium—the metals from which the implant was made—were also released into the blood and cerebral spinal fluid in some patients.”
“In March 2013, a jury in Los Angeles ordered Johnson & Johnson to pay more than $8.3 million in damages to a Montana man in the first of more than 10,000 lawsuits pending against the company in connection with the now-recalled DePuy hip.”
“Some lawyers and industry analysts have estimated that the suits ultimately will cost Johnson & Johnson billions of dollars to resolve.”
JOHNSON & JOHNSON SCANDAL SIX: 2010 SHAREHOLDERS LAWSUIT AGAINST THE COMPANY.
Wikipedia: “In 2010 a group of shareholders sued the board for allegedly failing to take action to prevent serious failings and illegalities since the 1990s, including manufacturing problems, bribing officials, covering up adverse effects and misleading marketing for unapproved uses. The judge initially dismissed the case in September 2011, but allowed the plaintiffs opportunity to refile at a later time. In 2012 Johnson and Johnson proposed a settlement with the shareholders, whereby the company would institute new oversight, quality and compliance procedures binding for five years.”
SCANDAL SEVEN: THE JOHNSON & JOHNSON/BIEDERMAN AFFAIR.
From psychcentralcom: “The trickle of incriminating evidence against Dr. Joseph Biederman, a Harvard world-renowned child psychiatrist known for his advocacy of ‘pediatric bipolar disorder,’ has turned into a torrent — of emails and internal documents.”
“The New York Times reports, based upon the release of court documents containing internal documents and emails, that Dr. Biederman was allegedly paid by Johnson & Johnson (J&J) for his promotion of pediatric bipolar disorder and research into showing the efficacy of a [highly toxic and dangerous] drug used to treat it, Risperdal.”
“The Philadelphia Inquirer’s take: ‘Johnson & Johnson gave hundreds of thousands of dollars to a research center run by an influential child psychiatrist [Biederman] explicitly to generate data to help expand sales of the company’s antipsychotic drug Risperdal in children, according to court documents.”
Essentially, Biederman was the prime figure who convinced the psychiatric community that childhood bipolar disease was a real condition—and then took money to promote drug treatment for it, including Risperdal, a Johnson & Johnson drug. Johnson & Johnson paid Biederman to run a research center that would help the company market and sell the drug.
Note: there is no defining physical test of any kind that diagnoses pediatric bipolar disease. No blood test, urine test, brain scan, genetic assay.
JOHNSON & JOHNSON SCANDAL EIGHT: NOBODY GOES TO PRISON.
The assessed fines for scandals and crimes haven’t put the company out of business. Not by a long shot.
These Johnson & Johnson executives roam free.
What would they have to do to find themselves behind bars for 20 years?
Carpet-bomb the US?